Brinks, H J <br/><br/>
Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass?  [electronic resource] 

 -  Perfusion  Jan 2001 
 - 3-12 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0267-6591 
<br/><br/><label>Standard No.: </label>10.1177/026765910101600102  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anticoagulants--blood<br/>Antithrombin III--analysis<br/>Blood Coagulation Tests<br/>Blood Loss, Surgical<br/>Blood Transfusion--statistics & numerical data<br/>Cardiopulmonary Bypass<br/>Disseminated Intravascular Coagulation--prevention & control<br/>Drug Resistance<br/>Elective Surgical Procedures<br/>Female<br/>Fibrin Fibrinogen Degradation Products--analysis<br/>Fibrinolysis--drug effects<br/>Hemostasis--drug effects<br/>Heparin--blood<br/>Heparin Lyase--pharmacology<br/>Humans<br/>Intraoperative Complications--prevention & control<br/>Intraoperative Period<br/>Male<br/>Mediastinum--blood supply<br/>Middle Aged<br/>Peptide Hydrolases--analysis<br/>Pilot Projects<br/>Platelet Count<br/>Platelet Function Tests<br/>Postoperative Complications--prevention & control<br/>Postoperative Period<br/>Preanesthetic Medication<br/>Thrombocytopenia--prevention & control<br/>Thromboembolism--prevention & control<br/>Treatment Outcome